4.4 Toxicological Emergencies and Overdose Antidotes

4.4 Toxicological Emergencies and Overdose Antidotes

In critical care transport, toxicological emergencies represent high-acuity, dynamic scenarios. Flight crews must manage toxic exposures in confined environments, requiring careful planning around airway management, chemical antidotes, and hemodynamics. Rapid recognition of clinical syndromic patterns (toxidromes) is paramount for guiding resuscitation.

Toxidrome Identification

Rather than waiting for laboratory confirmation, flight crews must differentiate toxic ingestions and exposures using a standardized clinical matrix:

---

Tricyclic Antidepressants (TCAs) and Fast Sodium Channel Blockade

TCA toxicity (e.g., amitriptyline, nortriptyline) is characterized by rapid cardiovascular collapse, seizures, and metabolic acidosis. TCAs block cardiac fast sodium channels, slowing Phase 0 of the cardiac action potential. This leads to QRS prolongation (>100 ms predicts seizures, >120 ms predicts ventricular arrhythmias, particularly monomorphic ventricular tachycardia). On the electrocardiogram (ECG), the pathognomonic signature is a terminal R wave in lead aVR (>3 mm in height or an R/S ratio > 0.7).

Resuscitation and Target Therapy

• Sodium Bicarbonate (NaHCO3): Administer 1 to 2 mEq/kg IV bolus. This acts via a dual therapeutic mechanism:
  1. The sodium load increases extracellular sodium concentrations, which helps overcome the fast sodium channel blockade.
  2. Serum alkalinization (target pH 7.45 to 7.55) increases the fraction of non-ionized drug, reducing its binding affinity for cardiac sodium channels.
• Airway Management: Hyperventilation can assist in maintaining respiratory alkalosis, but sodium bicarbonate boluses remain the primary therapy. Class IA and IC antiarrhythmics (e.g., procainamide, flecainide) are strictly contraindicated as they worsen sodium channel blockade. Lidocaine is the preferred alternative for refractory ventricular dysrhythmias.

---

Calcium Channel Blocker (CCB) and Beta-Blocker (BB) Overdoses

CCBs and BBs present with refractory bradycardia, hypotension, and cardiogenic shock. A key clinical differentiator is glycemic status. CCB overdose (specifically non-dihydropyridines like verapamil and diltiazem) blocks L-type calcium channels in pancreatic beta-islet cells, inhibiting insulin secretion and leading to marked hyperglycemia. BB overdose typically presents with euglycemia or hypoglycemia.

Resuscitation and Target Therapy

1. Calcium Support: Administer Calcium Chloride (10% solution, 1-2 g IV) or Calcium Gluconate (10% solution, 3-6 g IV). Calcium chloride is preferred for central lines as it has three times the elemental calcium concentration of gluconate; gluconate is preferred for peripheral access to prevent severe extravasation necrosis.
2. Glucagon: 5 to 10 mg IV bolus over 1-2 minutes, followed by an infusion of 2 to 5 mg/hour. Glucagon bypasses the beta-receptor, stimulating adenylate cyclase to increase intracellular cyclic AMP, enhancing myocardial contractility.
3. High-Dose Insulin Euglycemia Therapy (HIET): For refractory shock. Administer an insulin bolus of 1 unit/kg IV, followed by an infusion of 0.5 to 2 units/kg/hour, co-administered with dextrose (e.g., D50W boluses and D10W or D20W infusions) to maintain euglycemia. In shock, myocardial cells shift from fatty acid metabolism to carbohydrate metabolism. Insulin facilitates this metabolic switch, improving contractility.
4. Vasopressors: Epinephrine or norepinephrine, often titrated to high doses to overcome receptor blockade.

---

Environmental and Industrial Toxicants

Carbon Monoxide (CO) and Cyanide Poisoning

Smoke inhalation survivors often suffer from both CO and cyanide poisoning.

• Carbon Monoxide: Binds hemoglobin to form carboxyhemoglobin (COHb), shifting the oxygen-hemoglobin curve to the left and causing cellular hypoxia. Treatment is 100% high-flow oxygen, which decreases COHb half-life from ~320 minutes (room air) to ~80 minutes (100% O2). Hyperbaric oxygen (HBO) transfer is indicated for COHb > 25% (>15% in pregnancy), loss of consciousness, neurological signs, or ischemic chest pain.
• Cyanide: Inhibits cytochrome c oxidase in the mitochondrial electron transport chain, causing aerobic shutdown and lactic acidosis (>8 mmol/L). Treatment is Hydroxocobalamin (Cyanokit), 5 g IV over 15 minutes, which binds cyanide to form cyanocobalamin (Vitamin B12). Avoid older antidote kits containing sodium nitrite if carbon monoxide poisoning is suspected, as nitrites induce methemoglobinemia, further reducing oxygen delivery.

Organophosphates (Cholinergic Crisis)

Acetylcholinesterase inhibition leads to acetylcholine buildup. Presentation: SLUDGEM/DUMBELS. The killer "Bs" (bronchospasm, bronchorrhea, bradycardia) cause death.

• Atropine: Start at 2 to 5 mg IV, doubling the dose every 3 to 5 minutes (e.g., 2 mg, 4 mg, 8 mg, 16 mg) until bronchial secretions dry. The therapeutic endpoint is resolution of bronchorrhea and bronchospasm, not pupil dilation or heart rate.
• Pralidoxime (2-PAM): 1 to 2 g IV over 15 to 30 minutes to reactivate acetylcholinesterase before the enzyme undergoes irreversible "aging."
• Benzodiazepines: Administered aggressively to prevent and treat seizures.

Other Essential Antidotes

• Acetaminophen (APAP): N-acetylcysteine (NAC) replenishes glutathione stores, preventing NAPQI-mediated hepatic necrosis. The Rumack-Matthew Nomogram guides therapy between 4 and 24 hours post-ingestion.
• Hydrofluoric Acid (HF): Causes severe systemic hypocalcemia and hypomagnesemia. Treated with Calcium Gluconate (topical gel, subcutaneous infiltration, nebulized for inhalation, or arterial/venous infusion).